Evidence map›Paper›PMID 42210343›Full record

Trial reportBMC medical informatics and decision making2026

Sustainability of an electronic technology-based intervention in general practice targeting improved detection and monitoring of the interrelated chronic vascular diseases.

Julia L Jones, Koen Simons, Jo-Anne Manski-Nankervis, Peter Shane Hamblin, Natalie G Lumsden, Maximilian P De Courten, Edward D Janus, Craig L Nelson

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Julia L JonesUniversity of Melbourne, Melbourne, Australia. julia.jones@wh.org.au.ORCID 0000-0002-1266-4731
Koen SimonsUniversity of Melbourne, Melbourne, Australia.ORCID 0000-0002-6534-2277
Jo-Anne Manski-NankervisUniversity of Melbourne, Melbourne, Australia.ORCID 0000-0003-2153-3482
Peter Shane HamblinUniversity of Melbourne, Melbourne, Australia.ORCID 0000-0002-6280-865X
Natalie G LumsdenUniversity of Melbourne, Melbourne, Australia.ORCID 0000-0002-7471-2487
Maximilian P De CourtenMitchell Institute for Education and Health Policy, Victoria, Australia.ORCID 0000-0001-9997-9359
Edward D JanusUniversity of Melbourne, Melbourne, Australia.
Craig L NelsonUniversity of Melbourne, Melbourne, Australia.ORCID 0000-0003-3548-4167

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic kidney disease (CKD), type 2 diabetes (T2D) and cardiovascular disease cause substantial morbidity and mortality. Our earlier randomised stepped-wedge trial targeted these conditions using an electronic technology audit tool combined with benchmarking, education, monitoring and support to general practices. This study aimed to determine if changes seen in the original trial persisted 12 months later.

methodsThe study commenced at completion of the original 80-week trial. Practices received: final training session, resource folder, ongoing electronic technology tool access; other intervention components were withdrawn. Active patients (≥3 visits within last 24 months) aged ≥ 18 years within eight practices were included. Pre-defined variables from the original trial for which the credible interval (CI) did not include one, as well as two additional variables were re-assessed 12 months later. De-identified data were analysed using R version 3.5.1 with Bayesian generalised linear mixed model with practice specific random intercept and linear slope for time. Net effect odds ratio (OR) reflects the combined outcome of the original trial and subsequent follow-up period.

results37,813 patients were included at study end. Net OR and 95% CI showed: increased CKD diagnostic testing in those at risk (OR 1.4, CI 1.2-1.6), increased coded CKD diagnosis (OR 1.9, CI 1.6-2.2) and increased uACR testing in patients with T2D (OR 1.9, CI 1.4-2.5). When considering the proportion of patients with CKD on recommended management among all active patients aged ≥ 18 years, there were also increased patients with CKD prescribed ACEI/ARBs (OR 1.8, CI 1.5-2.3) and prescribed statins (OR 1.8, CI 1.4-2.2). There was no sustained increase in T2D diagnostic testing in those at risk.

conclusionsImprovements strengthened in five areas including three out of four pre-defined variables that improved in the original trial and two additional variables that also showed improvement in the original trial, suggesting lasting benefits with ongoing electronic technology tool access. Further investigation incorporating control practices and qualitative research investigating which components best promote long-term changes would be beneficial. REGISTRATION NUMBER: ACTRN12617000335392. Date registered: 3 March 2017.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2General PracticeRenal Insufficiency, ChronicAgedDigital HealthFemaleHumansMaleMiddle AgedChronic kidney diseaseDiabetesElectronic medical recordsGeneral practice

Identifiers

PMID42210343
PMCPMC13411737

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.